Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits
Alexander G. Mathioudakis, Wim Janssens, Pradeesh Sivapalan, et al.
Thorax (2020) Vol. 75, Iss. 6, pp. 520-527
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 70
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
Andrew Higham, Alexander G. Mathioudakis, Jørgen Vestbo, et al.
European Respiratory Review (2020) Vol. 29, Iss. 158, pp. 200199-200199
Open Access | Times Cited: 98
COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
Hamish McAuley, Kate Hadley, Omer Elneima, et al.
ERJ Open Research (2020) Vol. 7, Iss. 1, pp. 00718-2020
Open Access | Times Cited: 78
Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease
Sarah de Oliveira Rodrigues, Carolina Medina Coeli da Cunha, Giovanna Martins Valladão Soares, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 979-979
Open Access | Times Cited: 66
Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development
Jennifer Kricker, Clive P. Page, Fridrik Runar Gardarsson, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1404-1433
Open Access | Times Cited: 59
Regulation of lung epithelial cell senescence in smoking-induced COPD/emphysema by microR-125a-5p via Sp1 mediation of SIRT1/HIF-1a
Hao Wu, Huimin Ma, Lumin Wang, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 2, pp. 661-674
Open Access | Times Cited: 57
The Complex Association between COPD and COVID-19
Nikhil T Awatade, Peter Wark, Andrew S. L. Chan, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3791-3791
Open Access | Times Cited: 25
Plasmonic Alloys Enhanced Metabolic Fingerprints for the Diagnosis of COPD and Exacerbations
Haiyang Su, Yuanlin Song, Shouzhi Yang, et al.
ACS Central Science (2024) Vol. 10, Iss. 2, pp. 331-343
Open Access | Times Cited: 10
Lung Microbiota: From Healthy Lungs to Development of Chronic Obstructive Pulmonary Disease
Marija Stanković
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1403-1403
Open Access | Times Cited: 1
COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations
Jing Yuan Tan, Edwin Philip Conceicao, Liang En Wee, et al.
Thorax (2020) Vol. 76, Iss. 5, pp. 512-513
Open Access | Times Cited: 64
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Alexander G. Mathioudakis, Fekri Abroug, Àlvar Agustí, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 5, pp. 2102006-2102006
Open Access | Times Cited: 44
IgE is associated with exacerbations and lung function decline in COPD
Marek Lommatzsch, Thimoteus Speer, Christian Herr, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Impact of COVID-19 on Hospital Admissions for COPD Exacerbation: Lessons for Future Care
Michael Lawless, Mark Burgess, Stephen C Bourke
Medicina (2022) Vol. 58, Iss. 1, pp. 66-66
Open Access | Times Cited: 28
The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease
Akaninyene Otu, Chris Kosmidis, Alexander G. Mathioudakis, et al.
Infection (2023) Vol. 51, Iss. 4, pp. 813-829
Open Access | Times Cited: 22
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis
Efthymia Papadopoulou, Jan Hansel, Zsόfia Lázár, et al.
European Respiratory Review (2023) Vol. 32, Iss. 167, pp. 220141-220141
Open Access | Times Cited: 18
Extracellular vesicles and COPD: foe or friend?
Jiankang Wu, Yiming Ma, Yan Chen
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Role of extracellular vesicles in chronic lung disease
Anne Trappe, Seamas C. Donnelly, Paul McNally, et al.
Thorax (2021) Vol. 76, Iss. 10, pp. 1047-1056
Open Access | Times Cited: 36
Treatable Traits in COPD – A Proposed Approach
João Cardoso, António Jorge Ferreira, Miguel Guimarães, et al.
International Journal of COPD (2021) Vol. Volume 16, pp. 3167-3182
Open Access | Times Cited: 33
Blood urea nitrogen to serum albumin ratio: a good predictor of in-hospital and 90-day all-cause mortality in patients with acute exacerbations of chronic obstructive pulmonary disease
Zixiong Zeng, Xiaocui Ke, Shan Gong, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Impact of acute exacerbations of COPD on patients' health status beyond pulmonary function: A scoping review
Ana Machado, Marina Barusso-Grüninger, Jana De Brandt, et al.
Pulmonology (2022) Vol. 29, Iss. 6, pp. 518-534
Open Access | Times Cited: 23
Engineering a Point-of-Care Paper-Microfluidic Electrochemical Device Applied to the Multiplexed Quantitative Detection of Biomarkers in Sputum
Manuel Gutiérrez‐Capitán, Ana Sanchís, Estela O. Carvalho, et al.
ACS Sensors (2023) Vol. 8, Iss. 8, pp. 3032-3042
Open Access | Times Cited: 14
An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials
Mario Cazzola, Paola Rogliani, Peter J. Barnes, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 4, pp. 374-394
Closed Access | Times Cited: 13
Managing exacerbations of COPD: how much progress have we made?
Federico Baraldi, Míriam Barrecheguren, Alberto Papi, et al.
European Respiratory Society eBooks (2024)
Closed Access | Times Cited: 5
Characteristics, treatments, in-hospital and long-term outcomes among inpatients with acute exacerbation of chronic obstructive pulmonary disease in China: sex differences in a large cohort study
Jiarui Zhang, Qun Yi, Chen Zhou, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Targeting CCL2-CCR2 signaling pathway alleviates macrophage dysfunction in COPD via PI3K-AKT axis
Yue Dong, Ying Dong, Chengyue Zhu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top